Abstract A243: Characterization of NMS‐E628, a small molecule inhibitor of anaplastic lymphoma kinase with antitumor efficacy in ALK‐dependent lymphoma and non‐small cell lung cancer models-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abstract A243: Characterization of NMS‐E628, a small molecule inhibitor of anaplastic lymphoma kinase with antitumor efficacy in ALK‐dependent lymphoma and non‐small cell lung cancer models

Published:2009-12-10 Issue: Volume: Page:
ISSN:
Container-title:Therapeutic Agents - Small Molecule Kinase Inhibitors
language:
Short-container-title:

Author:

Ardini Elena,Menichincheri Maria,De Ponti Cristina,Amboldi Nadia,Saccardo Maria Beatrice,Texido Gemma,Russo Micaela,Orsini Paolo,Bandiera Tiziano,Lombardi Borgia Andrea,Isacchi Antonella,Pesenti Enrico,Colotta Francesco,Magnaghi, Paola,Galvani Arturo,Medical Nerviano

Publisher

American Association for Cancer Research

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An updated Review on Therapeutic Potential of Entrectinib as a Promising TrK, ROS 1, and ALK Inhibitor in Solid Tumors and Lung Cancer;Journal of Pharmaceutical Research International;2021-09-20

2. Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy;Current Medicinal Chemistry;2020-09-25

3. Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib;Medical Oncology;2018-04-17

4. Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence;Medical Oncology;2017-04-25

5. Neurotrophic tyrosine kinase gene fusions: another opportunity for targeting in lung cancer;Lung Cancer Management;2016-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP